Cargando…
Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker
BACKGROUND: Fibroblasts play important roles in several cancers. It was hypothesized that cholangiocarcinoma (CCA)-associated fibroblasts (Cfs) differ from non-tumorigenic liver fibroblasts (Lfs) in their gene expression profiles resulting in the capability to promote cancer. Periostin (PN) is a mul...
Autores principales: | Utispan, Kusumawadee, Thuwajit, Peti, Abiko, Yoshimitsu, Charngkaew, Komgrid, Paupairoj, Anucha, Chau-in, Siri, Thuwajit, Chanitra |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841583/ https://www.ncbi.nlm.nih.gov/pubmed/20096135 http://dx.doi.org/10.1186/1476-4598-9-13 |
Ejemplares similares
-
Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells
por: Singsuksawat, Ekapot, et al.
Publicado: (2018) -
Periostin induces epithelial-to-mesenchymal transition via the integrin α5β1/TWIST-2 axis in cholangiocarcinoma
por: Sonongbua, Jumaporn, et al.
Publicado: (2020) -
Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis
por: Thuwajit, Chanitra, et al.
Publicado: (2017) -
DNA Methylation Markers Improve the Sensitivity of Endoscopic Retrograde Cholangiopancreatography-Based Brushing Cytology in Extrahepatic Cholangiocarcinoma
por: Prachayakul, Varayu, et al.
Publicado: (2017) -
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
por: Oo, Khine Kyaw, et al.
Publicado: (2021)